. Anon and . Unaids_factsheet_fr, , 2018.

. Anon, UNAIDS Global report 2010 | Rapport ONUSIDA sur l'épidémie mondiale de sida 2010, 2018.

. Anon, Prévalence du VIH, total (% de la population âgée de 15 à 49 ans) | Data, 2018.

. Anon, , 2018.

. P. Anon and . Pdf, , 2018.

S. Baral, F. Sifakis, F. Cleghorn, and C. Beyrer, Elevated risk for HIV infection among men who have sex with men in low-and middle-income countries 2000-2006: a systematic review, PLoS Med, vol.4, p.339, 2007.

S. D. Baral, T. Poteat, S. Strömdahl, A. L. Wirtz, T. E. Guadamuz et al., Worldwide burden of HIV in transgender women: a systematic review and meta-analysis, Lancet Infect Dis, vol.13, pp.214-236, 2013.

D. E. Landoh, A. A. Maboudou, K. Deku, and P. V. Pitche, Distribution of new HIV infections among key risk population groups in Togo, Pan Afr Med J, vol.19, p.341, 2014.

. Anon, La balance a penché -ONUSIDA annonce que 19,5 millions de personnes restent en vie grâce aux traitements et le taux de mortalité due au SIDA a été divisé par deux depuis, 2005.

A. Karim, Q. Sibeko, S. Baxter, and C. , Preventing HIV infection in women: a global health imperative, Clin Infect Dis, vol.50, issue.3, pp.122-129, 2010.

T. De-oliveira, A. Kharsany, and T. Gräf, Transmission networks and risk of HIV infection in, The Lancet HIV, vol.4, pp.41-50, 2017.

S. Mtetwa, J. Busza, S. Chidiya, S. Mungofa, and F. Cowan, You are wasting our drugs': health service barriers to HIV treatment for sex workers in Zimbabwe, BMC Public Health, vol.13, p.698, 2013.

. Anon, La prévention du VIH au sein des populations clés, 2018.

A. Unaids--key-populations and . Atlas, , 2018.

B. M. Mathers, L. Degenhardt, and H. Ali, HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, Lancet, vol.375, pp.1014-1042, 2010.

. Anon, , 2018.

. Anon, , 2018.

P. M. Sharp and B. H. Hahn, Origins of HIV and the AIDS pandemic, Cold Spring Harb Perspect Med, vol.1, p.6841, 2011.

A. F. Aghokeng, A. Ayouba, and E. Mpoudi-ngole, Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions, Infect Genet Evol, vol.10, pp.386-96, 2010.

M. Schröder and A. G. Bowie, An arms race: innate antiviral responses and counteracting viral strategies, Biochem Soc Trans, vol.35, pp.1512-1516, 2007.

J. Plantier, M. Leoz, and J. E. Dickerson, A new human immunodeficiency virus derived from gorillas, Nat Med, vol.15, pp.871-873, 2009.

A. Lange and N. M. Ferguson, Antigenic Diversity, Transmission Mechanisms, and the Evolution of Pathogens Antia R, PLoS Computational Biology, vol.5, p.1000536, 2009.

H. Zhang, D. C. Tully, F. G. Hoffmann, J. He, C. Kankasa et al., Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants Ndhlovu LC, PLoS ONE, vol.5, p.9294, 2010.

F. Clavel, M. D. Hoggan, R. L. Willey, K. Strebel, M. A. Martin et al., Genetic recombination of human immunodeficiency virus, J Virol, vol.63, pp.1455-1464, 1989.

W. An and A. Telesnitsky, HIV-1 genetic recombination: experimental approaches and observations, AIDS Rev, vol.4, pp.195-212, 2002.

J. M. Coffin, HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy, Science, vol.267, pp.483-492, 1995.

D. L. Robertson, J. P. Anderson, and J. A. Bradac, HIV-1 nomenclature proposal, Science, vol.288, pp.55-61, 2000.

A. C. Van-der-kuyl and M. Cornelissen, Identifying HIV-1 dual infections, Retrovirology, vol.4, p.67, 2007.

C. M. Rousseau, G. H. Learn, and T. Bhattacharya, Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections, J Virol, vol.81, pp.4492-500, 2007.

K. Kozaczynska, M. Cornelissen, P. Reiss, F. Zorgdrager, and A. C. Van-der-kuyl, HIV-1 sequence evolution in vivo after superinfection with three viral strains, Retrovirology, vol.4, p.59, 2007.

B. G. Brenner, M. Oliveira, and F. Doualla-bell, HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture, AIDS, vol.20, pp.9-13, 2006.

H. Bolivar, R. Geffin, and G. Manzi, The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.52, pp.659-61, 2009.

M. S. Cohen, C. L. Gay, M. P. Busch, and F. M. Hecht, The Detection of Acute HIV Infection, The Journal of Infectious Diseases, vol.202, pp.270-277, 2010.

J. Louwagie, W. Janssens, and J. Mascola, Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin, J Virol, vol.69, pp.263-71, 1995.

J. Stebbing and G. Moyle, The clades of HIV: their origins and clinical significance, AIDS Rev, vol.5, pp.205-218, 2003.

P. J. Kanki, M. Peeters, and A. Guéye-ndiaye, Virology of HIV-1 and HIV-2: implications for Africa, AIDS, vol.11, pp.33-42, 1997.

F. Clavel, M. Guyader, D. Guétard, M. Sallé, L. Montagnier et al., Molecular cloning and polymorphism of the human immune deficiency virus type 2, Nature, vol.324, pp.691-696, 1986.

R. Marlink, P. Kanki, and I. Thior, Reduced rate of disease development after HIV-2 infection as compared to HIV-1, Science, vol.265, pp.1587-90, 1994.

C. A. Adjé-touré, R. Cheingsong, and J. G. Garcìa-lerma, Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d? Ivoire, AIDS, vol.17, pp.49-54, 2003.

K. Motomura, J. Chen, and W. Hu, Genetic Recombination between Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2, Two Distinct Human Lentiviruses, Journal of Virology, vol.82, pp.1923-1956, 2008.

A. B. Abecasis, P. Lemey, and N. Vidal, Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form, J Virol, vol.81, pp.8543-51, 2007.

M. Peeters and M. Chaix, Origine et diversité génétique du virus de l'immunodéficience humaine : d'où vient-il, où va-t-il ?, vol.17, p.13, 2013.

J. Hemelaar, E. Gouws, P. D. Ghys, and S. Osmanov, WHO-UNAIDS Network for HIV Isolation and Characterisation. Global trends in molecular epidemiology of HIV-1 during, AIDS, vol.25, pp.679-89, 2000.

A. Rambaut, D. L. Robertson, O. G. Pybus, M. Peeters, and E. C. Holmes, Human immunodeficiency virus. Phylogeny and the origin of HIV-1, Nature, vol.410, pp.1047-1055, 2001.

C. Kuiken, Genetic Analysis Reveals Epidemiologic Patterns in the Spread of Human Immunodeficiency Virus, American Journal of Epidemiology, vol.152, pp.814-836, 2000.

M. Sylla, A. Chamberland, and C. Boileau, Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso, Antivir Ther (Lond), vol.13, pp.141-149, 2008.

A. I. Maiga, D. B. Fofana, and A. C. Maiga, Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali, AIDS Res Hum Retroviruses, vol.29, pp.182-188, 2013.

A. Haidara, A. Chamberland, and M. Sylla, High level of primary drug resistance in Mali, HIV Med, vol.11, pp.404-415, 2010.

A. Derache, A. Maiga, and O. Traore, Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and, J Antimicrob Chemother, vol.62, pp.456-63, 2006.

H. J. Fleury, VIH-1, sous-types et CRF : différences dans la réponse aux traitements et la résistance aux antirétroviraux, p.7

H. Imamichi, O. Koita, and D. Dabitao, Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa, AIDS Res Hum Retroviruses, vol.25, pp.45-55, 2009.

C. Montavon, C. Toure-kane, and J. N. Nkengasong, CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, J Acquir Immune Defic Syndr, vol.29, pp.522-552, 2002.

. Anon and . Hiv, Circulating Recombinant Forms (CRFs), 2018.

K. A. Sepkowitz, AIDS--the first 20 years, N Engl J Med, vol.344, pp.1764-72, 2001.

M. Markowitz, H. Mohri, and S. Mehandru, Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report, Lancet, vol.365, pp.1031-1039, 2005.

C. W. Davis and R. W. Doms, HIV Transmission: Figure 1.: Closing All the Doors, The Journal of Experimental Medicine, vol.199, pp.1037-1077, 2004.

A. T. Haase, Early events in sexual transmission of HIV and SIV and opportunities for interventions, Annu Rev Med, vol.62, pp.127-166, 2011.

M. Marsh and A. Helenius, Virus entry: open sesame, Cell, vol.124, pp.729-769, 2006.

V. Maréchal, M. C. Prevost, C. Petit, E. Perret, J. M. Heard et al., Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis, J Virol, vol.75, pp.11166-77, 2001.

A. Engering, T. Geijtenbeek, and S. J. Van-vliet, The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells, J Immunol, vol.168, pp.2118-2144, 2002.

B. L. Shacklett and R. M. Greenblatt, Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications, Am J Reprod Immunol, vol.65, pp.230-271, 2011.

T. Igakura, J. C. Stinchcombe, and P. Goon, Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton, Science, vol.299, pp.1713-1719, 2003.

C. Jolly and Q. J. Sattentau, Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity, J Virol, vol.79, pp.12088-94, 2005.

T. Igakura, J. C. Stinchcombe, and P. Goon, Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton, Science, vol.299, pp.1713-1719, 2003.

C. Jolly and Q. J. Sattentau, Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity, J Virol, vol.79, pp.12088-94, 2005.

N. Sol-foulon, M. Sourisseau, and F. Porrot, ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation, EMBO J, vol.26, pp.516-542, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00292789

A. Alfsen, H. Yu, A. Magérus-chatinet, A. Schmitt, and M. Bomsel, HIV-1-infected Blood Mononuclear Cells Form an Integrin-and Agrin-dependent Viral Synapse to Induce Efficient HIV-1 Transcytosis across Epithelial Cell Monolayer, Molecular Biology of the Cell, vol.16, pp.4267-79, 2005.

C. M. Haggerty, E. Pitt, and R. F. Siliciano, The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatmentinterruption trials, Current Opinion in HIV and AIDS, vol.1, pp.62-70, 2006.

R. Medzhitov and D. Littman, HIV immunology needs a new direction, Nature, vol.455, p.591, 2008.

T. W. Chun, L. Carruth, and D. Finzi, Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection, Nature, vol.387, pp.183-191, 1997.

J. K. Wong, M. Hezareh, and H. F. Günthard, Recovery of replication-competent HIV despite prolonged suppression of plasma viremia, Science, vol.278, pp.1291-1296, 1997.

C. Rouzioux, V. Avettand-fenoel, and B. Autran, Immune responses and latent tissue reservoirs during the course of HIV-1 infection, Virologie, vol.17, pp.157-68, 2013.

J. Estaquier and B. Hurtrel,

, Med Sci (Paris), vol.24, pp.1055-60, 2008.

J. R. Bailey, A. R. Sedaghat, and T. Kieffer, Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells, J Virol, vol.80, pp.6441-57, 2006.

B. F. Keele, L. Tazi, and S. Gartner, Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1, J Virol, vol.82, pp.5548-61, 2008.

F. Louache, A. Henri, and A. Bettaieb, Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors, Blood, vol.80, pp.2991-3000, 1992.

G. K. Sahu, D. Paar, S. Frost, M. M. Smith, S. Weaver et al., Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells, J Med Virol, vol.81, pp.9-15, 2009.

N. Chomont, M. El-far, and P. Ancuta, HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nat Med, vol.15, pp.893-900, 2009.

P. Delobel, K. Sandres-sauné, and M. Cazabat, Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART, AIDS, vol.19, pp.1739-50, 2005.

C. Varol, S. Yona, and S. Jung, Origins and tissue-context-dependent fates of blood monocytes, Immunol Cell Biol, vol.87, pp.30-38, 2009.

M. J. Mcelrath, R. M. Steinman, and Z. A. Cohn, Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients, J Clin Invest, vol.87, pp.27-30, 1991.

S. Sonza, A. Maerz, N. Deacon, J. Meanger, J. Mills et al., Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes, J Virol, vol.70, pp.3863-3872, 1996.

S. Aquaro, R. Caliò, J. Balzarini, M. C. Bellocchi, E. Garaci et al., Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir, Antiviral Res, vol.55, pp.209-234, 2002.

N. Sharova, C. Swingler, M. Sharkey, and M. Stevenson, Macrophages archive HIV-1 virions for dissemination in trans, EMBO J, vol.24, pp.2481-2490, 2005.

S. Sonza, H. P. Mutimer, and R. Oelrichs, Monocytes harbour replication-competent, nonlatent HIV-1 in patients on highly active antiretroviral therapy, AIDS, vol.15, pp.17-22, 2001.

T. Zhu, D. Muthui, and S. Holte, Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy, J Virol, vol.76, pp.707-723, 2002.

S. Crowe, T. Zhu, and W. A. Muller, The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection, J Leukoc Biol, vol.74, pp.635-676, 2003.

R. Shen, H. E. Richter, and R. H. Clements, Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection, J Virol, vol.83, pp.3258-67, 2009.

M. Mohan, P. P. Aye, J. T. Borda, X. Alvarez, and A. A. Lackner, CCAAT/enhancer binding protein beta is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques, Am J Pathol, vol.173, pp.106-124, 2008.

T. Igarashi, C. R. Brown, and Y. Endo, Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans, Proceedings of the National Academy of Sciences, vol.98, pp.658-63, 2001.

M. J. Mcelrath, K. Smythe, and J. Randolph-habecker, Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.63, pp.263-71, 2013.

T. B. Geijtenbeek, D. S. Kwon, and R. Torensma, DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells, Cell, vol.100, pp.587-97, 2000.

A. Cimarelli, C. A. Duclos, and A. Gessain, Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians, J Acquir Immune Defic Syndr Hum Retrovirol, vol.10, pp.198-204, 1995.

J. Zhang and A. S. Perelson, Contribution of follicular dendritic cells to persistent HIV viremia, J Virol, vol.87, pp.7893-901, 2013.

H. B. Bernstein, M. C. Plasterer, S. E. Schiff, C. Kitchen, S. Kitchen et al., CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration, J Immunol, vol.177, pp.3669-76, 2006.

A. Cochrane, G. J. Hughes, R. A. Seaton, and P. Simmonds, First evidence of HIV infection of CD8 lymphocytes expressing CD4 during primary HIV-1 infection, AIDS, vol.19, pp.1237-1246, 2005.

J. M. Brenchley, B. J. Hill, and D. R. Ambrozak, T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis, J Virol, vol.78, pp.1160-1168, 2004.

D. G. Brooks, S. G. Kitchen, C. M. Kitchen, D. D. Scripture-adams, and J. A. Zack, Generation of HIV latency during thymopoiesis, Nat Med, vol.7, pp.459-64, 2001.

S. Moir, R. Lapointe, and A. Malaspina, CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir, J Virol, vol.73, pp.7972-80, 1999.

J. Zhang, D. T. Scadden, and C. S. Crumpacker, Primitive hematopoietic cells resist HIV-1 infection via p21, J Clin Invest, vol.117, pp.473-81, 2007.

C. C. Carter, A. Onafuwa-nuga, and L. A. Mcnamara, HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs, Nat Med, vol.16, pp.446-51, 2010.

J. A. Zack, S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip et al., HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure, Cell, vol.61, pp.213-235, 1990.

F. Maldarelli, S. Palmer, and M. S. King, ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia, PLoS Pathog, vol.3, p.46, 2007.

D. Persaud, Y. Zhou, J. M. Siliciano, and R. F. Siliciano, Latency in human immunodeficiency virus type 1 infection: no easy answers, J Virol, vol.77, pp.1659-65, 2003.

M. Stevenson, T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica, HIV-1 replication is controlled at the level of T cell activation and proviral integration, EMBO J, vol.9, pp.1551-60, 1990.

T. W. Chun, R. T. Davey, and M. Ostrowski, Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active antiretroviral therapy, Nat Med, vol.6, pp.757-61, 2000.

O. Lambotte, Y. Taoufik, M. G. De-goër, C. Wallon, C. Goujard et al., Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy, J Acquir Immune Defic Syndr, vol.23, pp.114-123, 2000.

Y. Han, K. Lassen, and D. Monie, Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes, J Virol, vol.78, pp.6122-6155, 2004.

K. Lassen, Y. Han, Y. Zhou, J. Siliciano, and R. F. Siliciano, The multifactorial nature of HIV-1 latency, Trends Mol Med, vol.10, pp.525-556, 2004.

T. Lenasi, X. Contreras, and B. M. Peterlin, Transcriptional interference antagonizes proviral gene expression to promote HIV latency, Cell Host Microbe, vol.4, pp.123-156, 2008.

M. Hermankova, J. D. Siliciano, and Y. Zhou, Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo, J Virol, vol.77, pp.7383-92, 2003.

C. Van-lint, Role of chromatin in HIV-1 transcriptional regulation, Adv Pharmacol, vol.48, pp.121-60, 2000.

A. Bertin and S. Mangenot,

, Med Sci (Paris), vol.24, pp.715-724, 2008.

C. L. Peterson and M. Laniel, Histones and histone modifications, Curr Biol, vol.14, pp.546-551, 2004.

D. Ray-gallet, A. Gérard, S. Polo, and G. Almouzni,

, Med Sci (Paris), vol.21, pp.384-393, 2005.

S. A. Williams and W. C. Greene, Regulation of HIV-1 latency by T-cell activation, Cytokine, vol.39, pp.63-74, 2007.

I. Du-chéné, E. Basyuk, and Y. Lin, Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency, EMBO J, vol.26, pp.424-459, 2007.

A. Girard, N. Rochereau, X. Roblin, C. Genin, and S. Paul, Rôle et ciblage de l'intégrine ?4?7 dans la physiopathologie des MICI et de l'infection par le VIH. médecine/sciences, vol.31, pp.895-903, 2015.

A. H. Patki, S. P. Zielske, S. F. Sieg, and M. M. Lederman, Preferential S phase entry and apoptosis of CD4(+) T lymphocytes of HIV-1-infected patients after in vitro cultivation, Clin Immunol, vol.97, pp.241-248, 2000.

M. J. Lenardo, S. B. Angleman, and V. Bounkeua, Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env, J Virol, vol.76, pp.5082-93, 2002.

D. L. Bolton, B. Hahn, E. A. Park, L. L. Lehnhoff, F. Hornung et al.,

, T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis, J Virol, vol.76, pp.5094-107, 2002.

L. Meyaard, S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. Keet et al., Programmed death of T cells in HIV-1 infection, Science, vol.257, pp.217-226, 1992.

K. C. Wolthers, G. Bea, and A. Wisman, T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover, Science, vol.274, pp.1543-1550, 1996.

C. J. Pitcher, C. Quittner, and D. M. Peterson, HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression, Nat Med, vol.5, pp.518-543, 1999.

C. E. Metroka, S. Cunningham-rundles, and M. Krim, Generalized lymphadenopathy in homosexual men: an update of the New York experience, Ann N Y Acad Sci, vol.437, pp.400-411, 1984.

U. Mathur-wagh, R. W. Enlow, and I. Spigland, Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome, Lancet, vol.1, pp.1033-1041, 1984.

M. Roederer, J. G. Dubs, M. T. Anderson, P. A. Raju, L. A. Herzenberg et al., CD8 naive T cell counts decrease progressively in HIV-infected adults, J Clin Invest, vol.95, pp.2061-2067, 1995.

M. A. Nokta, X. Li, J. Nichols, A. Pou, D. Asmuth et al., Homeostasis of Naive and Memory T Cell Subpopulations in Peripheral Blood and Lymphoid Tissues in the Context of Human Immunodeficiency Virus Infection, The Journal of Infectious Diseases, vol.183, pp.1336-1378, 2001.

R. P. Bucy, R. D. Hockett, and C. A. Derdeyn, Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues, Journal of Clinical Investigation, vol.103, pp.1391-1399, 1999.

T. W. Schacker, P. L. Nguyen, and G. J. Beilman, Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis, Journal of Clinical Investigation, vol.110, pp.1133-1142, 2002.

T. Mohan, S. Bhatnagar, D. L. Gupta, and D. N. Rao, Current understanding of HIV-1 and T-cell adaptive immunity: progress to date, Microb Pathog, vol.73, pp.60-69, 2014.

D. Emilie, M. Peuchmaur, and M. C. Maillot, Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes, Journal of Clinical Investigation, vol.86, pp.148-59, 1990.

M. J. Boyle, M. F. Berger, and M. Tschuchnigg, Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients, Clin Exp Immunol, vol.92, pp.100-105, 1993.

P. Galanaud, The in vivo expression of cytokine genes in humans, J Lipid Mediat Cell Signal, vol.9, pp.37-41, 1994.

C. Trumpfheller, K. Tenner-racz, P. Racz, B. Fleischer, and S. Frosch, Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response, Clin Exp Immunol, vol.112, pp.92-101, 1998.

R. S. Veazey, M. Demaria, and L. V. Chalifoux, Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection, Science, vol.280, pp.427-458, 1998.

A. T. Haase, Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues, Annu Rev Immunol, vol.17, pp.625-56, 1999.

G. Pantaleo, C. Graziosi, and J. F. Demarest, HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease, Nature, vol.362, pp.355-363, 1993.

A. J. Martinot, M. Meythaler, and L. Pozzi, Acute SIV infection in sooty mangabey monkeys is characterized by rapid virus clearance from lymph nodes and absence of productive infection in germinal centers, PLoS ONE, vol.8, p.57785, 2013.

G. F. Burton, B. F. Keele, J. D. Estes, T. C. Thacker, and S. Gartner, Follicular dendritic cell contributions to HIV pathogenesis, Semin Immunol, vol.14, pp.275-84, 2002.

A. M. Mowat and J. L. Viney, The anatomical basis of intestinal immunity, Immunol Rev, vol.156, pp.145-66, 1997.

J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin et al., Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature, vol.434, pp.1093-1100, 2005.

S. Mehandru and S. Dandekar, Role of the gastrointestinal tract in establishing infection in primates and humans, Curr Opin HIV AIDS, vol.3, pp.22-29, 2008.

P. Lawrence, A. Zimmer, and S. Paul, Infection muqueuse par le virus VIH-1: mécanismes, conséquences, perspectives de vaccination, Revue Francophone des Laboratoires, pp.45-54, 2009.

S. A. Yukl, S. Gianella, and E. Sinclair, Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy, J Infect Dis, vol.202, pp.1553-61, 2010.

C. J. Miller, P. Vogel, N. J. Alexander, S. Dandekar, A. G. Hendrickx et al., Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques, Lab Invest, vol.70, pp.255-62, 1994.

G. Van-marle, M. J. Gill, D. Kolodka, L. Mcmanus, T. Grant et al., Compartmentalization of the gut viral reservoir in HIV-1 infected patients, Retrovirology, vol.4, p.87, 2007.

V. Avettand-fenoel, L. Hocqueloux, and M. Müller-trutwin, Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART, J Med Virol, vol.83, pp.1499-507, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00657572

M. C. Cumont, V. Monceaux, and L. Viollet, TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus, Cell Death Differ, vol.14, pp.1747-58, 2007.

M. A. Poles, W. J. Boscardin, and J. Elliott, Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals, J Acquir Immune Defic Syndr, vol.43, pp.65-73, 2006.

J. Pudney and D. Anderson, Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome, Am J Pathol, vol.139, pp.149-60, 1991.

G. J. Nuovo, J. Becker, A. Simsir, M. Margiotta, G. Khalife et al., HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization, Am J Pathol, vol.144, pp.1142-1150, 1994.

P. Gupta, C. Leroux, and B. K. Patterson, Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen, J Infect Dis, vol.182, pp.79-87, 2000.
URL : https://hal.archives-ouvertes.fr/hal-01601210

M. Leruez-ville, M. De-almeida, and A. Tachet, Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen, AIDS, vol.16, pp.2267-73, 2002.

A. J. Quayle, C. Xu, K. H. Mayer, and D. J. Anderson, T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen, J Infect Dis, vol.176, pp.960-968, 1997.

R. Pearce-pratt and D. M. Phillips, Studies of adhesion of lymphocytic cells: implications for sexual transmission of human immunodeficiency virus, Biol Reprod, vol.48, pp.431-476, 1993.

S. K. Pillai, B. Good, and S. K. Pond, Semen-specific genetic characteristics of human immunodeficiency virus type 1 env, J Virol, vol.79, pp.1734-1776, 2005.

P. M. Sheth, C. Kovacs, and K. S. Kemal, Persistent HIV RNA shedding in semen despite effective antiretroviral therapy, AIDS, vol.23, pp.2050-2054, 2009.

A. Marcelin, R. Tubiana, and S. Lambert-niclot, Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma, AIDS, vol.22, pp.1677-1686, 2008.

P. Gupta, K. B. Collins, and D. Ratner, Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system, J Virol, vol.76, pp.9868-76, 2002.

R. W. Coombs, P. S. Reichelderfer, and A. L. Landay, Recent observations on HIV type-1 infection in the genital tract of men and women, AIDS, vol.17, pp.455-80, 2003.

-. Hartigan, D. J. Connor, A. K. Van-rompay, K. Kanwar, B. Mccune et al., SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment, Sci Transl Med, vol.4, pp.136-69, 2012.

T. Fischer-smith, S. Croul, and A. Adeniyi, Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy, Am J Pathol, vol.164, pp.2089-99, 2004.

K. C. Williams, S. Corey, and S. V. Westmoreland, Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS, J Exp Med, vol.193, pp.905-920, 2001.

K. Takahashi, S. L. Wesselingh, D. E. Griffin, J. C. Mcarthur, R. T. Johnson et al., Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry, Ann Neurol, vol.39, pp.705-716, 1996.

J. N. Blankson, D. Persaud, and R. F. Siliciano, The challenge of viral reservoirs in HIV-1 infection, Annu Rev Med, vol.53, pp.557-93, 2002.

M. A. Cosenza, M. Zhao, S. Q. Lee, and S. C. , Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis, Brain Pathol, vol.12, pp.442-55, 2002.

K. A. Thompson, M. J. Churchill, and P. R. Gorry, Astrocyte specific viral strains in HIV dementia, Ann Neurol, vol.56, pp.873-880, 2004.

M. Churchill and A. Nath, Where does HIV hide? A focus on the central nervous system, Curr Opin HIV AIDS, vol.8, pp.165-174, 2013.

S. Letendre, J. Marquie-beck, and E. Capparelli, Validation of the CNS PenetrationEffectiveness rank for quantifying antiretroviral penetration into the central nervous system, Arch Neurol, vol.65, pp.65-70, 2008.

L. M. Casey, Y. Lan, E. Cho, K. M. Maltby, T. Gridley et al., Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development, Developmental Dynamics, vol.235, pp.1830-1874, 2006.

P. A. Murray, Periodontal diseases in patients infected by human immunodeficiency virus, Periodontology, vol.6, pp.50-67, 20001994.

P. Robinson, A. Adegboye, R. Rowland, S. Yeung, and N. Johnson, Periodontal diseases and HIV infection, Oral Diseases, vol.8, pp.144-50, 2002.

S. R. Torres, A. Garzino-demo, T. F. Meiller, V. Meeks, and J. Ma, Salivary histatin-5 and oral fungal colonisation in HIV+ individuals, Mycoses, vol.52, pp.11-16, 2009.

C. M. Cobb, B. L. Ferguson, N. T. Keselyak, L. A. Holt, S. R. Macneill et al., A TEM/SEM study of the microbial plaque overlying the necrotic gingival papillae of HIVseropositive, necrotizing ulcerative periodontitis, J Periodont Res, vol.38, pp.147-55, 2003.

J. Arthos, C. Cicala, and E. Martinelli, HIV-1 envelope protein binds to and signals through integrin ?4?7, the gut mucosal homing receptor for peripheral T cells, Nature Immunology, vol.9, pp.301-310, 2008.

M. Mataftsi, L. Skoura, and D. Sakellari, HIV infection and periodontal diseases: an overview of the post-HAART era: HIV infection and periodontal diseases, Oral Diseases, vol.17, pp.13-25, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00613820

A. Vacharaksa, A. C. Asrani, and K. H. Gebhard, Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells, Retrovirology, vol.5, p.66, 2008.

R. B. Kumar, D. M. Maher, M. C. Herzberg, and P. J. Southern, Expression of HIV receptors, alternate receptors and co-receptors on tonsillar epithelium: implications for HIV binding and primary oral infection, Virol J, vol.3, p.25, 2006.

A. Kohli, A. Islam, and D. L. Moyes, Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected Palaniyar N, PLoS ONE, vol.9, p.98077, 2014.

S. M. Dorosko and R. I. Connor, Primary Human Mammary Epithelial Cells Endocytose HIV-1 and Facilitate Viral Infection of CD4

. +-t-lymphocytes, Journal of Virology, vol.84, pp.10533-10575, 2010.

M. Blasi, B. Balakumaran, and P. Chen, Renal epithelial cells produce and spread HIV-1 via T-cell contact, AIDS, vol.28, pp.2345-53, 2014.

P. Chen, B. K. Chen, and A. Mosoian, Virological Synapses Allow HIV-1 Uptake and Gene Expression in Renal Tubular Epithelial Cells, Journal of the American Society of Nephrology, vol.22, pp.496-507, 2011.

L. A. Bruggeman, M. D. Ross, and N. Tanji, Renal epithelium is a previously unrecognized site of HIV-1 infection, J Am Soc Nephrol, vol.11, pp.2079-87, 2000.

D. Marras, L. A. Bruggeman, and F. Gao, Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy, Nature Medicine, vol.8, pp.522-528, 2002.

G. Canaud, N. Dejucq-rainsford, and V. Avettand-fenoel, The Kidney as a Reservoir for HIV-1 after Renal Transplantation, Journal of the American Society of Nephrology, vol.25, pp.407-426, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01121764

L. Kong, W. Maya, and M. E. Moreno-fernandez, Low-level HIV infection of hepatocytes, Virology Journal, vol.9, p.157, 2012.

A. C. Tuyama, F. Hong, and Y. Saiman, Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis, Hepatology, vol.52, pp.612-634, 2010.

M. Hashimoto, H. Nasser, and F. Bhuyan, Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1, The Journal of Immunology, vol.195, pp.4341-50, 2015.

C. R. Wira, M. Rodriguez-garcia, and M. V. Patel, The role of sex hormones in immune protection of the female reproductive tract, Nature Reviews Immunology, vol.15, pp.217-247, 2015.

D. Vitali, J. M. Wessels, and C. Kaushic, Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract, AIDS Res Ther, vol.14, p.39, 2017.

V. H. Ferreira, J. K. Kafka, and C. Kaushic, Influence of Common Mucosal Co-Factors on HIV Infection in the Female Genital Tract, American Journal of Reproductive Immunology, vol.71, pp.543-54, 2014.

A. Buvé, V. Jespers, T. Crucitti, and R. N. Fichorova, The vaginal microbiota and susceptibility to HIV, AIDS, vol.28, pp.2333-2377, 2014.

B. Huang, J. M. Fettweis, J. P. Brooks, K. K. Jefferson, and G. A. Buck, The Changing Landscape of the Vaginal Microbiome, Clinics in Laboratory Medicine, vol.34, pp.747-61, 2014.

M. C. Eastment, R. S. Mcclelland, and . Vaginal, AIDS, vol.32, pp.687-98, 2018.

N. R. Klatt, R. Cheu, and K. Birse, Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women, Science, vol.356, pp.938-983, 2017.

S. M. Dillon, E. J. Lee, and C. V. Kotter, An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia, Mucosal Immunol, vol.7, pp.983-94, 2014.

E. A. Mutlu, A. Keshavarzian, and J. Losurdo, A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects, PLoS Pathog, vol.10, p.1003829, 2014.

I. Vujkovic-cvijin, R. M. Dunham, and S. Iwai, Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism, Science Translational Medicine, vol.5, pp.193-91, 2013.

C. A. Lozupone, M. E. Rhodes, C. P. Neff, A. P. Fontenot, T. B. Campbell et al., HIVinduced alteration in gut microbiota: Driving factors, consequences, and effects of antiretroviral therapy, Gut Microbes, vol.5, pp.562-70, 2014.

P. K. Mukherjee, J. Chandra, and M. Retuerto, Oral Mycobiome Analysis of HIV-Infected Patients: Identification of Pichia as an Antagonist of Opportunistic Fungi Hogan DA, PLoS Pathogens, vol.10, p.1003996, 2014.

Y. Cai, C. Sugimoto, and M. Arainga, Preferential Destruction of Interstitial Macrophages over Alveolar Macrophages as a Cause of Pulmonary Disease in Simian Immunodeficiency Virus-Infected Rhesus Macaques, The Journal of Immunology, vol.195, pp.4884-91, 2015.

. Anon, En finir avec le sida -Progresser vers les cibles 90-90-90 -Synthèse, p.24

. Anon, , 2018.

A. , ONUSIDA alerte que les progrès ralentissent et que le temps est compté pour atteindre les objectifs de 2020 en matière de VIH, 2018.

I. Fakoya, Á. Arco, D. Monge, and S. , HIV testing history and access to treatment among migrants living with HIV in Europe, Journal of the International AIDS Society, vol.21, p.25123, 2018.

A. Fiche and . Statistiques-mondiales, Personnes vivant avec le VIH, Personnes vivant avec le VIH qui ont accès à la thérapie antirétrovirale, Nouvelles infections à VIH, Décès liés au sida, VIH/tuberculose, InvestissementsUNAIDS_FactSheet_fr.pdf. Available at, 2015.

. 9. Anon and . Pdf, , 2018.

, Consolidated guidelines on HIV testing services: 5Cs: consent, confidentiality, counselling, correct results, and connection, 2015.

. Anon,

. 9. Anon and . Pdf, 705084B7A83F2C4CC31B6A23D2B8740?sequence=1. Accessed, 2018.

J. K. Craigo and P. Gupta, HIV-1 in genital compartments: vexing viral reservoirs, Curr Opin HIV AIDS, vol.1, pp.97-102, 2006.

J. K. Wong and S. A. Yukl, Tissue reservoirs of HIV, Current Opinion in HIV and AIDS, vol.11, pp.362-70, 2016.

S. Taylor and S. Davies, Antiretroviral drug concentrations in the male and female genital tract: implications for the sexual transmission of HIV, Curr Opin HIV AIDS, vol.5, pp.335-378, 2010.

L. J. Else, S. Taylor, D. J. Back, and S. H. Khoo, Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract, Antiviral Therapy, vol.16, pp.1149-67, 2011.

O. Launay, M. Tod, and I. Tschöpe, Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study, Antiviral Therapy, vol.16, pp.843-52, 2011.

S. A. Yukl, A. K. Shergill, and K. Mcquaid, Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy, AIDS, vol.24, pp.2451-60, 2010.

A. E. Depincé, E. Dussert, and D. Vergnon-miszczycha, The Genotyping Resistance Profile of the Pol Gene Detected in Blood of Newly Diagnosed HIV-Positive Men Is Durably Archived in the Gut Whatever the Time of Initiation of cART, Intervirology, vol.59, pp.256-61, 2016.

C. Delaugerre, Barrière génétique à la résistance des antirétroviraux, Médecine et Maladies Infectieuses, vol.40, pp.1-10, 2010.

M. W. Tang and R. W. Shafer, HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications, Drugs, vol.72, pp.1-25, 2012.

M. Aoki, D. Das, and H. Hayashi, Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance Prasad VR, vol.9, 2018.

A. Santos, D. M. Tebit, and M. S. Lalonde, Effect of Natural Polymorphisms in the HIV

, CRF02_AG Protease on Protease Inhibitor Hypersusceptibility, vol.56, pp.2719-2744, 2012.

P. Lawrence, M. Lutz, and H. Saoudin, Analysis of Polymorphism in the Protease and Reverse Transcriptase Genes of HIV Type 1 CRF02-AG Subtypes From Drug-Naive Patients From Saint, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, pp.396-404, 2006.

A. Blanc, F. Bonnet, and F. Brun-vezinet, Groupe d'experts pour la prise en charge du VIH, p.15, 2016.

. Netgen, Les tests de résistance aux antirétroviraux en pratique clinique, Revue Médicale Suisse. Available, 2018.

L. Araújo, D. M. Junqueira, R. M. De-medeiros, M. Matte, and M. Almeida-se-de, Naturally occurring resistance mutations to HIV-1 entry inhibitors in subtypes B, C, and CRF31_BC, J Clin Virol, vol.54, pp.6-10, 2012.

J. Vercauteren and A. Vandamme, Algorithms for the interpretation of HIV-1 genotypic drug resistance information, Antiviral Research, vol.71, pp.335-377, 2006.

Y. Singh and M. Mars, HIV Drug-Resistant Patient Information Management, Analysis, and Interpretation, JMIR Research Protocols, vol.1, p.3, 2012.

L. M. Hofstra, N. Sauvageot, and J. Albert, Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe, Clinical Infectious Diseases, vol.62, pp.655-63, 2016.

D. Castor, A. Low, and T. Evering, Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City, J Acquir Immune Defic Syndr, vol.61, pp.1-8, 2012.

J. L. Mbisa, E. Fearnhill, and D. T. Dunn, Evidence of Self-Sustaining Drug Resistant HIV

, Lineages Among Untreated Patients in the United Kingdom, Clin Infect Dis, vol.61, pp.829-865, 2015.

B. Brenner, M. A. Wainberg, and H. Salomon, Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study, Int J Antimicrob Agents, vol.16, pp.429-463, 2000.

M. Chen, Y. Ma, and Y. Su, HIV-1 genetic characteristics and transmitted drug resistance among men who have sex with men in Kunming, China. PLoS ONE, vol.9, p.87033, 2014.

J. M. Waters, W. O'neal, and K. L. White, Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients, Antivir Ther (Lond), vol.14, pp.231-240, 2009.

L. Bracciale, M. Colafigli, and M. Zazzi, Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors, Journal of Antimicrobial Chemotherapy, vol.64, pp.607-622, 2009.

L. Fabeni, C. Alteri, and N. Orchi, Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy, PLoS ONE, vol.10, p.135325, 2015.

J. D. Barbour, T. Wrin, and R. M. Grant, Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults, J Virol, vol.76, pp.11104-11116, 2002.

F. Clavel and A. J. Hance, HIV drug resistance, N Engl J Med, vol.350, pp.1023-1058, 2004.

L. M. Hofstra, N. Sauvageot, and J. Albert, Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe, Clin Infect Dis, 2015.

A. Somda, L. Sangare, and M. Soro, Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Clin Infect Dis, vol.54, issue.4, pp.317-319, 2012.

N. I. Nii-trebi, S. Ibe, and J. S. Barnor, HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naïve Patients after the Implementation of Antiretroviral Therapy in, PLoS ONE, vol.8, p.71972, 2013.

R. Kantor, D. Bettendorf, and R. J. Bosch, HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1-Infected Men and Women, AIDS Clinical Trials Group Study A5077 Ambrose Z, vol.9, p.93537, 2014.

A. S. Hassan, S. M. Mwaringa, and C. A. Obonyo, Low Prevalence of Transmitted HIV Type 1 Drug Resistance Among Antiretroviral-Naive Adults in a Rural HIV Clinic in Kenya, AIDS Research and Human Retroviruses, vol.29, pp.129-164, 2013.

N. Wadonda-kabondo, R. Banda, and K. Moyo, Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and, Clin Infect Dis, vol.54, pp.324-327, 2012.

R. H. Archer, C. Dykes, and P. Gerondelis, Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture, J Virol, vol.74, pp.8390-401, 2000.

G. Yebra, M. De-mulder, and Á. Holguín, Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain, PLoS ONE, vol.8, p.64293, 2013.

A. I. Maiga, D. B. Fofana, and A. C. Maiga, Transmitted Antiretroviral Drug Resistance in Newly HIV-Infected and Untreated Patients in Ségou and Bamako, Mali, AIDS Research and Human Retroviruses, vol.29, pp.182-188, 2013.

E. Dam, R. Quercia, and B. Glass, Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss, PLoS Pathog, vol.5, p.1000345, 2009.

V. Ragupathy, J. Zhao, and O. Wood, Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon, Virol J, vol.8, p.185, 2011.

J. J. Eron, D. A. Cooper, and R. T. Steigbigel, Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebocontrolled trials, Lancet Infect Dis, vol.13, pp.587-96, 2013.

I. Malet, S. Fourati, and C. Charpentier, The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype, J Antimicrob Chemother, vol.66, pp.2827-2857, 2011.

S. Gianella, D. M. Smith, and M. V. Vargas, Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1-Infected Men Who Have Sex With Men, Clinical Infectious Diseases, vol.57, pp.441-448, 2013.

C. Solas, A. Lafeuillade, P. Halfon, S. Chadapaud, G. Hittinger et al., Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients, Antimicrob Agents Chemother, vol.47, pp.238-281, 2003.

G. Liuzzi, A. Chirianni, and M. Zaccarelli, Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay, In Vivo, vol.18, pp.509-521, 2004.

C. Soulie, D. Descamps, and M. Grudé, Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma, J Antimicrob Chemother, vol.70, pp.566-72, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01983962

C. Béguelin, M. Vázquez, and M. Bertschi, Viral escape in the CNS with multidrugresistant HIV-1, J Int AIDS Soc, vol.17, 2014.

B. Osborne, P. M. Sheth, and T. J. Yi, Impact of Antiretroviral Therapy Duration and Intensification on Isolated Shedding of HIV-1 RNA in Semen, Journal of Infectious Diseases, vol.207, pp.1226-1260, 2013.

K. S. Kemal, C. M. Ramirez, and H. Burger, Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1, AIDS Res Hum Retroviruses, vol.28, pp.1766-74, 2012.

M. Balamane, M. A. Winters, and S. C. Dalai, Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance § ~!, The Open Virology Journal, vol.4, pp.88-93, 2010.

V. A. Fonner, S. L. Dalglish, and C. E. Kennedy, Effectiveness and safety of oral HIV preexposure prophylaxis for all populations, AIDS, vol.30, pp.1973-83, 2016.

L. M. Adams and B. H. Balderson, HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report, AIDS Care, vol.28, pp.1154-1162, 2016.

S. Mccormack, D. T. Dunn, and M. Desai, Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, The Lancet, vol.387, pp.53-60, 2016.

N. S. Wong, T. H. Kwan, and O. Tsang, Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?, Sci Rep, vol.8, p.11641, 2018.

J. D. Auerbach, S. Kinsky, G. Brown, and V. Charles, Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV, AIDS Patient Care STDS, vol.29, pp.102-112, 2015.

. Anon and . Unaids_jc2764_en, , 2018.

A. Karim, Q. , A. Karim, S. S. Frohlich, and J. A. , Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, vol.329, pp.1168-74, 2010.

J. M. Marrazzo, G. Ramjee, and B. A. Richardson, Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women, New England Journal of Medicine, vol.372, pp.509-527, 2015.

M. Memmi, T. Bourlet, and B. Pozzetto, Use of vaginal rings charged with antiviral drugs for preventing HIV infection in women, Future Virology, vol.9, pp.227-257, 2014.

. Anon, Two Large Studies Show IPM's Monthly Vaginal Ring Helps Protect Women Against HIV | International Partnership For Microbicides, 2018.

J. T. Clark, M. R. Clark, and N. B. Shelke, Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy Tachedjian G, PLoS ONE, vol.9, p.88509, 2014.

D. K. Smith, L. A. Grohskopf, and R. J. Black, Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services, MMWR Recomm Rep, vol.54, pp.1-20, 2005.

D. M. Cardo, D. H. Culver, and C. A. Ciesielski, A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group, N Engl J Med, vol.337, pp.1485-90, 1997.

J. M. Baeten, R. Heffron, and L. Kidoguchi, Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda Siegfried N, PLOS Medicine, vol.13, p.1002099, 2016.

. Anon, , 2016.

E. M. Gardner, M. P. Mclees, J. F. Steiner, D. Rio, C. Burman et al., The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection, Clin Infect Dis, vol.52, pp.793-800, 2011.

J. D. Shelton and . Hiv/aids, ARVs as HIV prevention: a tough road to wide impact, Science, vol.334, pp.1645-1651, 2011.

R. G. Wamai, B. J. Morris, and S. A. Bailis, Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa, Journal of the International AIDS Society, vol.14, p.49, 2011.

R. H. Gray, G. Kigozi, and D. Serwadda, Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial, The Lancet, vol.369, pp.657-66, 2007.

R. C. Bailey, S. Moses, and C. B. Parker, Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial, The Lancet, vol.369, pp.643-56, 2007.

Y. Ganor, Z. Zhou, and J. Bodo, The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages, Mucosal Immunology, vol.6, pp.776-86, 2013.

Z. Zhou, N. Barry-de-longchamps, and A. Schmitt, HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells, PLoS Pathog, vol.7, p.1002100, 2011.

H. A. Weiss, M. A. Quigley, and R. J. Hayes, Male circumcision and risk of HIV infection in subSaharan Africa: a systematic review and meta-analysis, AIDS, vol.14, pp.2361-70, 2000.

. Anon, , 2018.

S. Pinkham, C. Stoicescu, and B. Myers, Developing Effective Health Interventions for Women Who Inject Drugs: Key Areas and Recommendations for Program Development and Policy. Advances in Preventive Medicine, 2012.

. Anon, , 2018.

M. L. Rich, A. C. Miller, and P. Niyigena, Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda, J Acquir Immune Defic Syndr, vol.59, pp.35-42, 2012.

E. H. Geng, D. R. Bangsberg, and N. Musinguzi, Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a samplingbased approach, J Acquir Immune Defic Syndr, vol.53, pp.405-416, 2010.

S. Rosen, M. P. Fox, and C. J. Gill, Patient Retention in Antiretroviral Therapy Programs in SubSaharan Africa: A Systematic Review Sepulveda-Amor J, PLoS Medicine, 2007.

. Anon, OMS | Les services de prise en charge de l'infection à VIH négligent les adolescents, 2018.

T. Roberts, J. Cohn, K. Bonner, and S. Hargreaves, Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges, Clin Infect Dis, vol.62, pp.1043-1051, 2016.

A. Aidsinfo and . Unaids, , 2018.

P. Msellati, F. A. Ndongo, F. Hejoaka, and B. Nacro, Impediments to HIV testing in HIVinfected children and teenagers in Africa: look for them where they are! Médecine et Santé Tropicales, pp.10-14

G. Wu and M. H. Zaman, Low-cost tools for diagnosing and monitoring HIV infection in lowresource settings, Bull World Health Organ, vol.90, pp.914-934, 2012.

P. K. Drain and C. Rousseau, Point-of-care diagnostics: extending the laboratory network to reach the last mile, Current Opinion in HIV and AIDS, vol.12, pp.175-81, 2017.

F. Louni, L. Gac, S. Rumi, S. , L. Roque et al., A-22: La généralisation des TROD VIH ne risque-t-elle pas d'augmenter le sous-diagnostic des hépatites virales ?, Médecine et Maladies Infectieuses, vol.44, p.24, 2014.

A. Sarr, Dépistage communautaire par tests rapides (TROD) VIH en France sur une période de trois ans, p.7, 2012.

S. Tonen-wolyec, M. Filali, S. Mboup, and L. Bélec, HIV self-testing in Africa: stakes and challenges, Médecine et Santé Tropicales, pp.20184-20189

P. Pai, N. Sharma, J. Shivkumar, and S. , Supervised and Unsupervised Self-Testing for HIV in High-and Low-Risk Populations: A Systematic Review Weiser SD, PLoS Medicine, vol.10, p.1001414, 2013.

A. T. Choko, P. Macpherson, and E. L. Webb, Accuracy, Safety, and Linkage into Care over Two Years of Promoting Annual Self-Testing for HIV in, A Community-Based Prospective Study Bangsberg DR, vol.12, p.1001873, 2015.

H. Thirumurthy, S. H. Masters, S. N. Mavedzenge, S. Maman, E. Omanga et al., Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and postpartum care in Kenya: a cohort study, Lancet HIV, vol.3, pp.266-274, 2016.

. Anon, A71_41Rev1-fr, 2018.

S. Lecher, J. Williams, and P. N. Fonjungo, Progress with Scale-Up of HIV Viral Load Monitoring -Seven Sub-Saharan African Countries, MMWR Morbidity and Mortality Weekly Report, vol.65, pp.1332-1337, 2015.

A. Johannessen, C. Garrido, and N. Zahonero, Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania, Clin Infect Dis, vol.49, pp.976-81, 2009.

C. Hirtz and S. Lehmann, Blood sampling using "dried blood spot": a clinical biology revolution underway?, Annales de Biologie Clinique, vol.73, pp.25-37, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01842461

. 9. Anon and . Pdf, , 2018.

P. W. Smit, K. A. Sollis, and S. Fiscus, Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis Paxton WA, PLoS ONE, vol.9, p.86461, 2014.

A. D. Mbida, S. Sosso, and P. Flori, Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon, J Acquir Immune Defic Syndr, vol.52, pp.9-16, 2009.

F. Taieb, T. Hong, T. Ho, and H. T. , First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam Sandstrom P, PLOS ONE, vol.13, p.191920, 2018.

E. Fajardo, C. A. Metcalf, and P. Chaillet, Prospective Evaluation of Diagnostic Accuracy of Dried Blood Spots from Finger Prick Samples for Determination of HIV-1 Load with the NucliSENS Easy-Q HIV-1 Version 2.0 Assay in Malawi, Journal of Clinical Microbiology, vol.52, pp.1343-51, 2014.

C. Zeh, K. Ndiege, and S. Inzaule, Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in, PLOS ONE, vol.12, p.179316, 2017.

J. Chang, A. De-sousa, and J. Sabatier, Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique Ceccherini-Silberstein F, PLOS ONE, vol.12, p.181054, 2017.

S. C. Aitken, C. L. Wallis, W. Stevens, T. R. De-wit, and R. Schuurman, Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping Paxton WA, PLOS ONE, vol.10, p.131541, 2015.

T. A. Lillie, J. Baer, D. Adams, J. Zhao, and R. C. Wolf, Think global, act local: the experience of Global Fund and PEPFAR joint cascade assessments to harmonize and strengthen key population HIV programmes in eight countries, Journal of the International AIDS Society, vol.21, p.25125

K. B. Biello, C. E. Oldenburg, and S. A. Safren, Multiple syndemic psychosocial factors are associated with reduced engagement in HIV care among a multinational, online sample of HIV-infected MSM in Latin America, AIDS Care, vol.28, issue.1, pp.84-91, 2016.

K. E. Lancaster, D. Cernigliaro, R. Zulliger, and P. F. Fleming, HIV care and treatment experiences among female sex workers living with HIV in sub-Saharan Africa: A systematic review, Afr J AIDS Res, vol.15, pp.377-86, 2016.

. Anon, , 2018.

, The Lancet HIV. U=U taking off in 2017, vol.4, p.475, 2017.

K. N. Deering, P. Bhattacharjee, and H. L. Mohan, Violence and HIV risk among female sex workers in Southern India, Sex Transm Dis, vol.40, pp.168-74, 2013.

M. R. Decker, A. L. Wirtz, and C. Pretorius, Estimating the impact of reducing violence against female sex workers on HIV epidemics in Kenya and Ukraine: a policy modeling exercise, Am J Reprod Immunol, vol.69, issue.1, pp.122-154, 2013.

R. Lorway, R. O'brien, and N. , Sex worker-led structural interventions in India: a case study on addressing violence in HIV prevention through the Ashodaya Samithi collective in Mysore, Indian J Med Res, vol.135, pp.98-106, 2012.

. 9. Anon and . Pdf, , 2018.

A. Oms-|-réseau-de-laboratoires and . Who, , 2018.

D. S. Boyle, D. A. Lehman, and L. Lillis, Rapid Detection of HIV-1 Proviral DNA for Early Infant Diagnosis Using Recombinase Polymerase Amplification, mBio, vol.4, 2013.

M. K. Haleyur-giri-setty and I. K. Hewlett, Point of Care Technologies for HIV, AIDS Research and Treatment, vol.2014, pp.1-20, 2014.

Z. Ndlovu, E. Fajardo, and E. Mbofana, Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe Yotebieng M, vol.13, p.193577, 2018.

B. Meggi, L. Vojnov, and N. Mabunda, Performance of point-of-care birth HIV testing in primary health care clinics: An observational cohort study Hsiao N, PLOS ONE, vol.13, p.198344, 2018.

L. Scott, N. Gous, S. Carmona, and W. Stevens, Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa, J Clin Microbiol, vol.53, pp.1616-1637, 2015.

H. Albert, R. R. Nathavitharana, C. Isaacs, M. Pai, C. M. Denkinger et al.,

, Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?, Eur Respir J, vol.48, pp.516-541, 2016.

S. Zida, Développement d'approches PCR et implémentation pour l'amélioration de l'accès au diagnostic moléculaire des maladies infectieuses dans les pays à ressources limitées, p.116

A. , ONUSIDA révèle que près de 21 millions de personnes séropositives sont désormais sous traitement, 2018.

R. N. Shepard, J. Schock, and K. Robertson, Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments, J Clin Microbiol, vol.38, pp.1414-1422, 2000.

T. Bourlet, C. Cazorla, and P. Berthelot, Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva, AIDS, vol.15, pp.284-289, 2001.

A. Tachet, E. Dulioust, and D. Salmon, Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission, AIDS, vol.13, pp.823-854, 1999.

J. K. Ball, R. Curran, W. L. Irving, and A. A. Dearden, HIV-1 in semen: determination of proviral and viral titres compared to blood, and quantification of semen leukocyte populations, J Med Virol, vol.59, pp.356-63, 1999.

D. J. Chan and J. E. Ray, Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis, J Pharm Pharmacol, vol.59, pp.1451-62, 2007.

J. J. Eron, P. L. Vernazza, and D. M. Johnston, Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission, AIDS, vol.12, pp.181-189, 1998.

C. Barau, C. Delaugerre, and J. Braun, High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial, Antimicrob Agents Chemother, vol.54, pp.937-946, 2010.

D. Romero, J. Castilla, J. Hernando, V. Rodriguez, C. Garcia et al., Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study, BMJ, vol.340, pp.2205-2205, 2010.

P. Halfon, C. Giorgetti, and H. Khiri, Semen may harbor HIV despite effective HAART: another piece in the puzzle, PLoS ONE, vol.5, p.10569, 2010.

M. Zhang, B. Foley, and A. Schultz, The role of recombination in the emergence of a complex and dynamic HIV epidemic, Retrovirology, vol.7, p.25, 2010.

L. Vergne, L. Stuyver, M. Van-houtte, C. Butel, E. Delaporte et al., Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients, Journal of Clinical Virology, vol.36, pp.43-52, 2006.

S. Sungkanuparph, W. Manosuthi, S. Kiertiburanakul, N. Saekang, W. Pairoj et al., Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine, Journal of Clinical Virology, vol.41, pp.310-313, 2008.

. Anon, Principaux repères sur le VIH/sida, 2018.

J. Manasa, D. Katzenstein, S. Cassol, M. Newell, and D. Oliveira, for the Southern Afric T. Primary Drug Resistance in South Africa: Data from 10 Years of Surveys, AIDS Research and Human Retroviruses, vol.28, pp.558-65, 2012.

J. M. Afonso, G. Bello, M. L. Guimarães, M. Sojka, and M. G. Morgado, HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola, PLoS ONE, vol.7, p.42996, 2012.

N. I. Nii-trebi, S. Ibe, and J. S. Barnor, HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana, PLoS ONE, vol.8, p.71972, 2013.

R. Kantor, A. Delong, and M. Balamane, HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya, J Int AIDS Soc, vol.17, 2014.

J. Rusine, S. Jurriaans, and J. Van-de-wijgert, Molecular and phylogeographic analysis of human immuno-deficiency virus type 1 strains infecting treatment-naive patients from, PLoS ONE, vol.7, p.42557, 2012.

G. E. Imade, A. S. Sagay, and B. Chaplin, Short Communication: Transmitted HIV Drug Resistance in Antiretroviral-Naive Pregnant Women in North Central Nigeria, AIDS Research and Human Retroviruses, vol.30, pp.127-160, 2014.

J. Landier, A. Akonde, and C. Pizzocolo, Switch to second-line ART in West African routine care: incidence and reasons for switching, AIDS Care, vol.23, pp.75-83, 2011.

R. Granich, S. Gupta, and B. Hersh, Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden, PLoS ONE, vol.10, p.131353, 1990.

D. Koyalta, C. Charpentier, and J. Beassamda, High Frequency of Antiretroviral Drug Resistance among HIV-Infected Adults Receiving First-Line Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.49, pp.155-164, 2009.

C. Adawaye, J. Fokam, and E. Kamangu, Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study, BMC Research Notes, vol.10, 2017.

F. Taieb, T. H. Tram, and H. T. Ho, Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338), Open Forum Infect Dis, vol.3, p.142, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01818734

A. F. Aghokeng, L. Vergne, and E. Mpoudi-ngole, Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries, Antivir Ther (Lond), vol.14, pp.401-412, 2009.

C. C. King, S. R. Ellington, and N. L. Davis, Magnitude, and Correlates of HIV

, Genital Shedding in Women on Antiretroviral Therapy. The Journal of Infectious Diseases, vol.216, pp.1534-1574, 2017.

A. Keita, Y. Sereme, and S. Pillet, Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali, Journal of Antimicrobial Chemotherapy, 2018.

L. Andréoletti, G. Grésenguet, and N. Chomont, Comparison of washing and swabbing procedures for collecting genital fluids to assess shedding of human immunodeficiency virus type 1 (HIV-1) RNA in asymptomatic HIV-1-infected women, J Clin Microbiol, vol.41, pp.449-52, 2003.

M. Yan, S. J. Pamp, and J. Fukuyama, Nasal Microenvironments and Interspecific Interactions Influence Nasal Microbiota Complexity and S. aureus Carriage, Cell Host & Microbe, vol.14, pp.631-671, 2013.

O. González, J. Ebersole, and C. Huang, Oral infectious diseases: a potential risk factor for HIV virus recrudescence?, Oral Diseases, vol.15, pp.313-340, 2009.

S. Grignolo, B. Bruzzone, and L. Gabbi, Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study, Virulence, vol.8, pp.101-109, 2017.

S. Fourati, I. Malet, and S. Lambert, E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure, AIDS, vol.26, pp.1619-1643, 2012.

H. Xu, E. L. Asahchop, and M. Oliveira, Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations, J Virol, vol.85, pp.11300-11308, 2011.

T. L. Katzenstein, A. B. Petersen, and M. Storgaard, Phylogeny and resistance profiles of HIV-1 POL sequences from rectal biopsies and blood, Journal of Medical Virology, vol.82, pp.1103-1112, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00552409

L. Monno, G. Punzi, and T. Scarabaggio, Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART, J Med Virol, vol.70, pp.1-9, 2003.

C. Guillaume, N. 'guyen, Y. Brodard, V. Bani-sadr, F. Jaussaud et al., African ethnicity can influence immunological responses to highly active antiretroviral therapy and immunological success at 48 months: a retrospective pilot study, International Journal of Infectious Diseases, vol.17, pp.1259-62, 2013.

C. Rosin, L. Elzi, and C. Thurnheer, Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study: HIV/AIDS and women, HIV Medicine, vol.16, pp.319-344, 2015.

C. M. Puskas, J. I. Forrest, and S. Parashar, Women and Vulnerability to HAART NonAdherence: A Literature Review of Treatment Adherence by Gender from, Current HIV/AIDS Reports, vol.8, pp.277-87, 2000.

E. N. Essomba, D. Adiogo, D. C. Kedy, B. Amang, L. G. Lehman et al., Facteurs associés à la non observance thérapeutique des sujets adultes infectés par le VIH sous antirétroviraux dans un hôpital de référence à Douala, Pan African Medical Journal, vol.20, 2015.

O. Djarma, Y. Nguyen, F. Renois, A. Djimassal, F. Banisadr et al., Continuous free access to HAART could be one of the potential factors impacting on loss to follow-up in HAART-eligible patients living in a resource-limited setting, Transactions of The Royal Society of Tropical Medicine and Hygiene, vol.108, pp.735-743, 2014.

S. Zida, E. Tuaillon, and M. Barro, Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients Caliendo AM, Journal of Clinical Microbiology, vol.54, pp.1641-1644, 2016.

E. Messou, M. Chaix, and D. Gabillard, Increasing Rate of TAMs and Etravirine Resistance in HIV-1-Infected Adults Between 12 and 24 Months of Treatment: The VOLTART Cohort Study in, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.64, pp.211-220, 2013.

K. M. Stadeli and D. D. Richman, Rates of emergence of HIV drug resistance in resourcelimited settings: a systematic review, Antiviral Therapy, vol.18, pp.115-138, 2012.

J. L. Martinez-cajas, N. P. Pai, M. B. Klein, and M. A. Wainberg, Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008), Journal of the International AIDS Society, vol.12, p.11, 2009.

M. A. Wainberg, HIV-1 subtype distribution and the problem of drug resistance, AIDS, vol.18, issue.3, pp.63-68, 2004.

L. Andreoletti, K. Skrabal, and V. Perrin, Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women, J Clin Microbiol, vol.45, pp.1838-1880, 2007.